PTPIOTCPharmaceutical PreparationsFiscal year ends December 31

Petros Pharmaceuticals, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$0.00+0.00 (+5.56%)

Close on Oct 19, 2026

Market cap: $135.07K
P/E (TTM): –
Dividend yield: –

Earnings

Quarterly results announced on Form 8-K, Item 2.02

Quarter	Reported	Time	Revenue	EPS (GAAP)	EPS (adjusted)
Q3 FY2022 Ended Sep 30, 2022	Nov 15, 2022	Before market open	–	–	–
Q2 FY2022 Ended Jun 30, 2022	Aug 15, 2022	Before market open	–	–	–
Q1 FY2022 Ended Mar 31, 2022	Apr 4, 2022	During market hours	–	–	–

Press releases

Announcements Petros Pharmaceuticals filed with the SEC

Jun 20, 2025, 5:20 PM ET
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Feb 21, 2025, 5:15 PM ET
Petros Pharmaceuticals Announces Pricing of
Material agreement · Other events · EX-99.1 to Form 8-K
Jul 13, 2023, 4:41 PM ET
Petros Pharmaceuticals Announces Capital Raise
Material agreement · Unregistered share sale · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Nov 30, 2022, 4:05 PM ET
Petros Pharmaceuticals Announces Reverse Stock
Charter or bylaw amendment · Shareholder vote results · Regulation FD disclosure · EX-99.1 to Form 8-K
Nov 15, 2022, 8:30 AM ET
Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Aug 15, 2022, 9:16 AM ET
Petros Pharmaceuticals Reports Record Revenue and Gross Profit During
Results of operations · EX-99.1 to Form 8-K
Jul 28, 2022, 11:26 AM ET
NEW YORK, July 28, 2022 -- Petros Pharmaceuticals,
Other events · EX-99.1 to Form 8-K
Apr 26, 2022, 4:30 PM ET
Petros Pharmaceuticals, Inc. Engages Massachusetts
Other events · EX-99.1 to Form 8-K
Apr 4, 2022, 4:15 PM ET
Petros Pharmaceuticals Reports Year End 2021
Results of operations · EX-99.1 to Form 8-K
Dec 27, 2021, 5:02 PM ET
Petros Pharmaceuticals Announces $7.5 Million Offering
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Dec 1, 2021, 5:12 PM ET
Petros Pharmaceuticals Announces $10 Million Offering
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Nov 15, 2021, 9:00 PM ET
Petros Pharmaceuticals Reports Third Quarter Financial Results and
Results of operations · EX-99.1 to Form 8-K
Oct 15, 2021, 5:03 PM ET
was led by the company's largest shareholder
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K